According to Precigen's latest financial reports the company has a price-to-book ratio of 2.96.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.81 | 12.33% |
2022-12-31 | 2.51 | -64.93% |
2021-12-31 | 7.14 | -74.64% |
2020-12-31 | 28.2 | 125.8% |
2019-12-31 | 12.5 | 351.52% |
2018-12-31 | 2.76 | 7.52% |
2017-12-31 | 2.57 | -49.23% |
2016-12-31 | 5.06 | 1.44% |
2015-12-31 | 4.99 | -26.23% |
2014-12-31 | 6.76 | 11.67% |
2013-12-31 | 6.06 | |
2012-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Organovo ONVO | 1.63 | -44.96% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | 4.74 | 59.90% | ๐ฌ๐ง UK |
Novavax NVAX | -0.7984 | -126.96% | ๐บ๐ธ USA |
Novocure
NVCR | 3.75 | 26.63% | Jersey |